+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The lack of resistance development among candida isolates from immunocompromised patients on prolonged antifungal therapy



The lack of resistance development among candida isolates from immunocompromised patients on prolonged antifungal therapy



Pharmacotherapy 11(3): 267




(PDF emailed within 1 workday: $29.90)

Accession: 033856712

Download citation: RISBibTeXText


Related references

Development of resistance in candida isolates from patients receiving prolonged antifungal therapy. Antimicrobial Agents and ChemoTherapy 35(11): 2302-2305, 1991

Fluconazole resistance of candida albicans isolates from aids patients receiving prolonged antifungal therapy. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 311, 1992

Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy. Bmc Infectious Diseases 15: 340, 2016

Antifungal susceptibility patterns of colonized Candida species isolates from immunocompromised pediatric patients in five university hospitals. Iranian Journal of Microbiology 9(6): 363-371, 2018

Antifungal susceptibilities and epidemiology of yeast isolates from AIDS patients during prolonged antifungal therapy. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34(0): 176, 1994

Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates. Bmc Infectious Diseases 17(1): 727, 2018

Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy. Journal of Clinical Microbiology 44(2): 529-535, 2006

Prevalence of resistance mechanisms to azole antifungal agents in Candida albicans isolates from HIV-infected patients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 549, 1999

Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus. Archives of Oral Biology 56(6): 549-555, 2011

Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay. Antimicrobial Agents and ChemoTherapy 52(9): 3424-3426, 2008

Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study. Antimicrobial Agents and ChemoTherapy 60(3): 1500-1508, 2017

Identification, typing, antifungal resistance profile, and biofilm formation of Candida albicans isolates from Lebanese hospital patients. Biomed Research International 2014: 931372, 2015

The presence of fluconazole-resistant Candida dubliniensis strains among Candida albicans isolates from immunocompromised or otherwise debilitated HIV-negative Turkish patients. Revista Iberoamericana de Micologia 19(1): 44-48, 2003

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrobial Agents and ChemoTherapy 39(11): 2378-2386, 1995

Investigation of antifungal resistance and extracellular virulence factors of oropharyngeal Candida norvegensis isolates from bone marrow transplanted patients. International Journal of Antimicrobial Agents 19(Supplement 1): S76, 2002